Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Gan To Kagaku Ryoho. 2008 Nov;35(12):2109-11.

[A case of successful management of liver metastases of pancreatic carcinoma by hepatectomy and adjuvant chemotherapy].

[Article in Japanese]

Author information

  • 1Dept. of Surgery, Fujisaki Hospital.

Abstract

We have experienced a successful case of liver metastases from pancreatic ductal adenocarcinoma treated by hepatectomy and adjuvant chemotherapy. A 62-year-old male had undergone pancreatoduodenectomy for pancreatic ductal adenocarcinoma. Thirty days after the surgery, he was given a systemic administration of gemcitabine (GEM) at a dose of 1,000-1,400 mg/body biweekly. Serum CA19-9 was elevated about 8 months after the primary resection. In addition, abdominal CT scan revealed a hepatic metastatic lesion about 10 month after the surgery, We changed the protocol of the chemotherapy to a systemic administration of GEM at a dose of 1,200-1,400 mg/body once a week for 3 weeks with a 1-week rest. Serum CA19-9 was more elevated, so he underwent hepatectomy for liver metastases from pancreatic ductal adenocarcinoma 13 months after the primary surgery, and the adjuvant chemotherapy of GEM restarted at 21 days after the hepatectomy. He has survived without recurrence more than 14 months after the hepatectomy.

PMID:
19106539
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Sunmedia PierOnline
    Loading ...
    Write to the Help Desk